Published in J Mater Sci Mater Med on May 22, 2017
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell (2006) 12.72
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res (1988) 9.96
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett (2006) 3.94
Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov (2004) 3.68
Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release (2012) 3.41
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol (2012) 2.91
Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev (1990) 2.75
Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci (2003) 2.74
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A (2006) 2.55
Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release (2004) 2.43
The National Cancer Institute: cancer drug discovery and development program. Semin Oncol (1992) 2.24
Functionalized micellar systems for cancer targeted drug delivery. Pharm Res (2007) 1.90
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg (1998) 1.90
Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release (2001) 1.73
Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity. Clin Microbiol Infect (2004) 1.66
Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J Control Release (2004) 1.55
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release (2000) 1.50
Preparation and properties of a novel drug delivery system with both magnetic and biomolecular targeting. J Mater Sci Mater Med (2008) 1.36
Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol (2008) 1.33
Delivery of molecular and cellular medicine to solid tumors. J Control Release (1998) 1.27
Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci (2006) 1.20
PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. J Control Release (2011) 1.18
The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid). Pharm Res (1992) 1.15
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv. J Control Release (2007) 1.14
Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta (2009) 1.13
Local drug delivery to the brain. Adv Drug Deliv Rev (2002) 1.07
Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials (2003) 1.06
Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res A (2007) 1.05
Hydrolytic and enzymatic degradations of physically crosslinked hydrogels prepared from PLA/PEO/PLA triblock copolymers. J Mater Sci Mater Med (2002) 0.91
Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. J Biomed Mater Res (2000) 0.91
Simulation of the delivery of doxorubicin to hepatoma. Pharm Res (2001) 0.90
L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity. Int J Pharm (2008) 0.90
Biocompatibility of injectable chitosan-phospholipid implant systems. Biomaterials (2009) 0.90
Anomalous release of hydrophilic drugs from poly(epsilon-caprolactone) matrices. Mol Pharm (2007) 0.87
Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes. Parasite (2001) 0.87
Comparative studies of poly(ε-caprolactone) and poly(D,L-lactide) as core materials of polymeric micelles. J Microencapsul (2012) 0.86
Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Acta Biomater (2013) 0.86
Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants. Med Biol Eng Comput (2008) 0.85
Doxorubicin-loaded micelles based on multiarm star-shaped PLGA-PEG block copolymers: influence of arm numbers on drug delivery. J Mater Sci Mater Med (2015) 0.83
Preparation and in vitro characterization of SN-38-loaded, self-forming polymeric depots as an injectable drug delivery system. J Pharm Sci (2012) 0.82
SN-38:β-cyclodextrin inclusion complex for in situ solidifying injectable polymer implants. Conf Proc IEEE Eng Med Biol Soc (2011) 0.82
Membrane-encased polymer millirods for sustained release of 5-fluorouracil. J Biomed Mater Res (2002) 0.81
HPLC analysis and extraction method of SN-38 in brain tumor model after injected by polymeric drug delivery system. Exp Biol Med (Maywood) (2014) 0.80
Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins. J Pharm Biomed Anal (1990) 0.79
Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model. Exp Biol Med (Maywood) (2015) 0.79
Comparison of doxorubicin concentration profiles in radiofrequency-ablated rat livers from sustained- and dual-release PLGA millirods. Pharm Res (2004) 0.78
Biocompatibility study of glycofurol in rat brains. Exp Biol Med (Maywood) (2011) 0.78
Preparation and biocompatibility study of in situ forming polymer implants in rat brains. J Mater Sci Mater Med (2011) 0.78
Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin. J Mater Sci Mater Med (2013) 0.77
Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles. J Pharm Sci (2013) 0.77
Physical stability and lyophilization of poly(epsilon-caprolactone)-b-poly(ethyleneglycol)-b-poly(epsilon-caprolactone) micelles. J Nanosci Nanotechnol (2006) 0.77
Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme. Pharm Res (2016) 0.77
Paclitaxel-loaded polymeric depots as injectable drug delivery system for cancer chemotherapy of hepatocellular carcinoma. Pharm Dev Technol (2016) 0.76